Crystalvue Medical Corporation (TPEX:6527)
70.00
-0.60 (-0.85%)
Nov 20, 2026, 1:30 PM CST
Crystalvue Medical Revenue
Crystalvue Medical had revenue of 221.33M TWD in the quarter ending September 30, 2026, with 10.15% growth. This brings the company's total for the last twelve months to 894.60M, down -1.23% year-over-year. In the year 2025, Crystalvue Medical had annual revenue of 949.05M with 9.33% growth. That makes Crystalvue Medical the 32,052nd largest company in the world by revenue and 1,647th in Taiwan.
Revenue (ttm)
894.60M
Revenue Growth
-1.23%
P/S Ratio
1.98
Revenue / Employee
8.21M
Employees
109
Market Cap
1.77B
Revenue by Geography
- Europe 364.85M 38.4%
- North America 328.83M 34.6%
- Asia 236.21M 24.9%
- Others 19.17M 2.0%
Fiscal year ended Dec 31, 2025 See the full Crystalvue Medical breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 949.05M | 81.02M | 9.33% |
| Dec 31, 2024 | 868.03M | 44.07M | 5.35% |
| Dec 31, 2023 | 823.96M | 28.51M | 3.58% |
| Dec 31, 2022 | 795.46M | 73.84M | 10.23% |
| Dec 31, 2021 | 721.61M | 217.24M | 43.07% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| BenQ Medical Technology | 5.40B |
| St.Shine Optical | 3.63B |
| Nang Kuang Pharmaceutical | 2.09B |
| Chi Sheng Pharma & Biotech | 1.43B |
| ICARES Medicus | 1.31B |
| Concord Medical | 1.04B |
| Perfect Medical Industry | 886.30M |
| SciVision Biotech | 870.41M |